-
1
-
-
84857237867
-
Adoption of pharmacogenomic testing by US physicians: Results of a nationwide survey
-
Stanek, E.J. et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin. Pharmacol. Ther. 91, 450-458 (2012).
-
(2012)
Clin. Pharmacol. Ther.
, vol.91
, pp. 450-458
-
-
Stanek, E.J.1
-
2
-
-
0033569516
-
Pharmacogenomics: Translating functional genomics into rational therapeutics
-
Evans, W.E. & Relling, M.V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286, 487-491 (1999).
-
(1999)
Science
, vol.286
, pp. 487-491
-
-
Evans, W.E.1
Relling, M.V.2
-
3
-
-
67650642313
-
Clinically available pharmacogenomic tests
-
Flockhart, D.A., Skaar, T, Berlin, D.S. Klein, T.E. & Nguyen, A.T. Clinically available pharmacogenomic tests. Clin. Pharmacol. Ther. 86, 109-113 (2009).
-
(2009)
Clin. Pharmacol. Ther.
, vol.86
, pp. 109-113
-
-
Flockhart, D.A.1
Skaar, T.2
Berlin, D.S.3
Klein, T.E.4
Nguyen, A.T.5
-
4
-
-
52149112915
-
Pharmacogenetics of hypersensitivity to abacavir: From PGx hypothesis to confirmation to clinical utility
-
Hughes, A.R. et al. Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility. Pharmacogenomics J. 8, 365-374 (2008).
-
(2008)
Pharmacogenomics J.
, vol.8
, pp. 365-374
-
-
Hughes, A.R.1
-
5
-
-
64549105787
-
Pharmacogenetics in Europe: Barriers and opportunities
-
Gurwitz, D. et al. Pharmacogenetics in Europe: barriers and opportunities. Public Health Genomics 12, 134-141 (2009).
-
(2009)
Public Health Genomics
, vol.12
, pp. 134-141
-
-
Gurwitz, D.1
-
6
-
-
78449311355
-
What is clinical utility and why should we care? Clin
-
Lesko, L.J., Zineh, I. & Huang, S.-M. What is clinical utility and why should we care? Clin. Pharmacol. Ther. 88, 729-733 (2010).
-
(2010)
Pharmacol. Ther.
, vol.88
, pp. 729-733
-
-
Lesko, L.J.1
Zineh, I.2
Huang, S.-M.3
-
7
-
-
85027935630
-
Pharmacogenetic testing: Time for clinical practice guidelines
-
Amstutz, U. & Carleton, B.C. Pharmacogenetic testing: time for clinical practice guidelines. Clin. Pharmacol. Ther. 89, 924-927 (2011).
-
(2011)
Clin. Pharmacol. Ther.
, vol.89
, pp. 924-927
-
-
Amstutz, U.1
Carleton, B.C.2
-
8
-
-
77956967099
-
Application of a pharmacogenetic test adoption model to six oncology biomarkers
-
Faruki, H. & Lai-Goldman, M. Application of a pharmacogenetic test adoption model to six oncology biomarkers. Pers. Med. 7, 441-450 (2010).
-
(2010)
Pers. Med.
, vol.7
, pp. 441-450
-
-
Faruki, H.1
Lai-Goldman, M.2
-
9
-
-
23644449909
-
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools Deans of Education
-
DOI 10.1038/sj.tpj.6500312
-
Gurwitz, D. et al. Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J. 5, 221-225 (2005). (Pubitemid 41131714)
-
(2005)
Pharmacogenomics Journal
, vol.5
, Issue.4
, pp. 221-225
-
-
Gurwitz, D.1
Lunshof, J.E.2
Dedoussis, G.3
Flordellis, C.S.4
Fuhr, U.5
Kirchheiner, J.6
Licinio, J.7
Llerena, A.8
Manolopoulos, V.G.9
Sheffield, L.J.10
Siest, G.11
Torricelli, F.12
Vasiliou, V.13
Wong, S.14
-
10
-
-
79959990099
-
Personalized medicine: New genomics, old lessons
-
Offit, K. Personalized medicine: new genomics, old lessons. Hum. Genet. 130, 3-14 (2011).
-
(2011)
Hum. Genet.
, vol.130
, pp. 3-14
-
-
Offit, K.1
|